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Abstract
Background: Effective therapeutic options are limited for the management of chronic central serous
chorioretinopathy (CSCR) complicated by exudative retinal detachments (RD). The authors describe the resolution of
one such case following partial thickness scleral resection with mitomycin C.
Case presentation: This 39-year-old male presented with a unilateral inferior exudative RD in the right eye. There
was no history of steroid use either locally or systemically. The fundus fluorescein angiogram showed window
defects and leaks typical of chronic CSCR. The axial length was 21.06 mm in the right eye and 21 mm in the left
eye. Thickening of the ocular coats was evident on ocular ultrasound. Considering an axial length in the borderline-low
range inferotemporal and inferonasal partial thickness scleral resection with mitomycin C was performed. The
exudative RD resolved at 4 months.
Conclusion: Partial thickness scleral resection may be considered as an option for treating chronic CSCR patients with
borderline-low axial length complicated by exudative RD.
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Background
Exudative retinal detachment (RD) is a rare complication
of chronic central serous chorioretinopathy (CSCR, or
diffuse retinal pigment epitheliopathy, DRPE) [1, 2] and
is difficult to treat. Suggested etiopathogenesis of CSCR
includes increased choroidal vascular permeability,
hyperdynamic choroidal circulation, dilation of the Hal-
ler’s layer of large choroidal vessels [3], accumulation of
fluid in the outer choroid [4], pachychoroid disease [5],
and deranged retinal pigment epithelium (RPE) pump
mechanism [6].
Available treatment options for chronic CSCR are
avoidance of steroids, laser, photodynamic therapy,
transpupillary thermotherapy, anti-glucocorticosteroids
(oral rifampicin, ketoconazole, mifepristone, finasteride),
anti-Helicobacter pylori treatment [7], oral acetazol-
amide, intravitreal anti-vascular endothelial growth fac-
tor agents, and aspirin [6].
Idiopathic uveal effusion syndrome (UES) is another
important cause of exudative retinal and ciliochoroidal
detachment, which may be associated with nanophthal-
mos. Previously, it was suggested that vortex vein com-
pression by the thick sclera resulted in such
detachments in nanophthalmic eyes, which resolved
after vortex vein decompression [8]. However, due to the
hypoplastic/fragile nature of the vortex veins in such
cases, such a procedure could lead to intraoperative am-
putation or rupture of these veins [9]. Gass JD hypothe-
sized that the hampered permeability of the sclera to
protein rich subretinal and suprachoroidal fluid is the
cause of UES and that the ‘barrier effect of the sclera is
more important than vortex vein obstructing effect’ [9].
He has demonstrated the successful resolution of subret-
inal fluid in two such eyes within 3 months following
sclerectomies and sclerostomies away from the vortex
vein [9]. UES with nanophthalmos also benefits from
sclerectomy [10] as thick and abnormal sclera is present
in such cases. The authors describe the resolution of
subretinal fluid in a case of exudative RD in chronic
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CSCR with borderline-low axial length, following partial
thickness scleral resection with mitomycin C (MMC).
MMC has been used successfully for its modulatory
effects on wound healing in multiple ocular surgeries in-
cluding trabeculectomy, pterygium excision, kerato-
refractive surgeries, and sclerectomy for retinal detach-
ment in nanophthalmos [11–13]. In scleral resection,
MMC is thought to reduce scarring of the sclerectomy
bed and prevent recurrence of the exudative retinal de-
tachment due to the regeneration of thick sclera with
abnormally arranged collagen fibers [13]. Reported com-
plications of MMC include hypotony secondary to thin
cystic bleb following trabeculectomy, endophthalmitis,
and corneal or scleral melting [12]. However, we are un-
aware of any serious adverse effects of the drug when
used in conjunction with sclerectomy for nanophthal-
mos [12, 14].
Case presentation
A 39-year-old male presented with painless progressive
diminution of vision in the right eye (RE) of 5 years and
in the left eye (LE) of 6 months duration. There was no
history of chronic drug use, specifically, use of steroid in
any form. The visual acuity was 1/60 (RE) and 6/18 (LE).
There was no anterior chamber or retrolental cells in
both eyes and intraocular pressures were normal. The
RE had a bullous inferior RD involving the macula with
a smooth surface and shifting fluid. There was whitish
subretinal exudation inferior to the macula (fibrin,
Fig. 1a). The LE showed pigmentary changes at the pos-
terior pole and multiple pigment epithelial detachments
(PEDs) (Fig. 1b). No mass lesion or peripheral break was
detected in either eye. Fluorescein angiography (FA) of
the RE showed window defects at the posterior pole with
leaks at the nasal part of the window defect and infero-
nasal to the optic disc (Fig. 1c). There was no disc leak
or vasculitis. The LE revealed window defects with mul-
tiple PEDs. Optical coherence tomography (OCT) of the
RE revealed subfoveal fluid with some underlying hyper-
reflective material suggestive of fibrin and a serous PED
(Fig. 1d). OCT of the LE revealed multiple serous PEDs.
The sclero-chorioretinal thickness was 2 mm (RE)
and 2.01 mm (LE). Axial lengths were 21.06 mm (RE)
and 21 mm (LE). Serum cortisol level, blood pressure,
Fig. 1 Preoperative fundus findings of the patient. a Fundus photograph of the right eye shows inferior exudative retinal detachment with
subretinal exudation (fibrin) inferior to the macula. b Fundus photograph of the left eye shows pigmentary changes at the posterior pole
consistent with diffuse retinal pigment epitheliopathy. c Fluorescein angiography (late phase) of the right eye reveals an annular zone of small
hyper and hypofluorescent areas corresponding to the mottled appearance of the RPE with pooling of dye in the subretinal space. Most of the
hyperfluorescent areas being window defects with few increasing in size and intensity with time suggest active leaks. A small focal leaking area
of hyperfluorescence is also seen inferonasal to the disc. d Optical coherence tomography (OCT) of the right eye shows the neurosensory
detachment at the fovea with some underlying hyperreflective material suggestive of fibrin and a pigment epithelial detachment (PED)
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and kidney functions tests were normal. A diagnosis
of bilateral chronic CSCR with an exudative RD in
the RE was made. Some cases of CSR can undergo
spontaneous resolution. Thus at the first presentation,
the patient was advised to follow-up.
At 1 month, there was no change. Then a 2 month
trial of oral rifampicin 300 mg twice daily [15] was tried
without success. Laser was not considered as the trans-
retinal pigment epithelial leakage was not well defined.
Though photodynamic therapy (PDT) [6] has been stud-
ied extensively for chronic CSCR [16], its role in chronic
CSCR complicated by retinal detachment needs evalu-
ation. Our patient was given the option of PDT, but he
declined the therapy due to financial constraints. As the
exudative RD was not responding and the eye was small
in size, we felt that similar to nanophthalmic eyes, the
sclera may be the culprit by not allowing the resolution
of the subretinal fluid. Thus, we planned partial thick-
ness scleral resection in the RE as the eye was small with
increased thickness of the ocular coats like in
nanophthalmos. A proper informed consent for the pro-
cedure was obtained. Surgically, an area of 4 mm by
3 mm was marked on the sclera, 4 mm posterior to the
insertion of recti in inferotemporal and inferonasal
quadrants. Using a blade and crescent knife, a partial
thickness (more than 50 %) square of sclera was excised
from the marked areas. Mitomycin C 0.02 % was placed
on the scleral bed for 2 min after which a thorough wash
with the balanced salt solution was performed.
At 2 months, the vision of the right eye had improved
to 3/60 and the exudative detachment had started
regressing. At 4 months, the vision was 6/60 and the ex-
udative detachment had totally resolved (Fig. 2a). OCT
revealed resolution of subretinal fluid and marked reduc-
tion in the height of the PED with persistence of some
of the hyperreflective subretinal fibrin (Fig. 2b).
After 2 years of surgery, the right eye had achieved
a best-corrected visual acuity of 6/36. The right eye
had attached retina with a focal elevated pigmented
area at the fovea surrounded by hypopigmentation
(Fig. 2c). OCT showed the absence of subretinal fluid.
Few intraretinal cystoid spaces and a subretinal
mound presumably due to fibrin were visible (Fig. 2d).
The FFA revealed the absence of any active leak and
leopard spot like fluorescence in the inferior retina
reminiscent of previous retinal detachment (Fig. 2e).
The mid-phase indocyanine green angiogram (ICGA)
of the right eye was suggestive of DRPE. The foveal
center appeared dark, likely due to blocked fluores-
cence by the focal retinal pigment epithelial hyperpla-
sia as seen on the fundus image. Small pinpoint leaks
were visible superior to the disc (Fig. 2f ).
Fig. 2 The right eye 4 months (a,b) and 2 years (c,d,e,f) after scleral resection. a Four months postoperatively, fundus photograph of the right eye
shows total resolution of the exudative detachment with persisting diffuse retinal pigment epitheliopathy at the posterior pole. b Four months’
follow-up OCT shows resolution of subretinal fluid and marked reduction in height of the PED with persistence of some of the hyperreflective
subretinal fibrin. c The right fundus 2 years after surgery, revealing retinal pigment epithelial changes and the absence of subretinal fluid at the
posterior pole. d OCT of the right eye at 2 years after surgery shows the absence of subretinal fluid in the right eye. e The FFA revealed a leopard
spot like fluorescence inferiorly. f The mid-phase ICGA of the right eye showed a block fluorescence at the foveal center and small pin-point leaks
superior to the optic disc
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The left eye had retained 6/18 vision and showed
RPE changes and subretinal yellowish deposits
(Fig. 3a). The OCT showed PEDs temporal to the
fovea; and nasal intraretinal cystoid spaces (Fig. 3b).
The FFA of the left eye revealed areas of mottled
hyper and hypofluorescence with broad areas of stain-
ing, but no definitive focal leak could be identified
(Fig. 3c). ICGA (early phase) of the left eye showed
patchy granular fluorescence at the posterior pole,
and dilated large choroidal vessels inferior to the
fovea (Fig. 3d). Diffusely increased choroidal hyper-
fluorescence around this region at the posterior pole
persisting in the late phase, suggestive of increased
choroidal permeability was also seen. In the mid
phase, few active pin point leaks were also evident
(black arrowhead, Fig. 3e).
Conclusions
Causes of exudative RD include hypertension [17], Vogt-
Koyanagi-Harada syndrome, posterior scleritis, metasta-
sis, uveal effusion syndrome, nanophthalmos and other
ocular tumors. In our patient, blood pressure was nor-
mal and there was no evidence of intraocular inflamma-
tion. Our patient did not have pain and subtenon fluid
on ultrasound typical of posterior scleritis. Ocular tumor
or metastasis was ruled out by indirect ophthalmoscopy
and ocular ultrasound.
Uveal effusion syndrome was ruled out as there was
no ciliochoroidal detachment. The most important dif-
ferentials in our case included chronic CSCR [1] and ser-
ous RD secondary to nanophthalmos [18]. Considering
the clinical picture, fluorescein angiography and OCT
findings, our primary diagnosis was chronic CSCR. The
eye of our patient was not nanophthalmic by strict diag-
nostic criterion (axial length < 20 mm) [19], but it was
still a small eye with borderline axial length. The thick-
ness of the ocular coats was also increased. Thus, we hy-
pothesized that additionally in our patient there may be
a component of reduced transscleral outflow that is seen
in nanophthalmic eyes. This reduced outflow was prob-
ably unable to balance the marked exudative inflow due
to chronic CSCR and resulted in a persistent exudative
RD.
We have previously demonstrated the benefit of partial
thickness scleral resection with mitomycin C in
nanophthalmic eyes with exudative RD [12]. A similar
procedure was carried out in our patient. However,
chronic CSCR with exudative RD may also resolve spon-
taneously [2]. Yet a slow but dramatic resolution of the
subretinal fluid and improvement of visual acuity of our
Fig. 3 Evaluation of the left eye at 2 years’ follow-up. a The fundus of the left eye at 2-years follow-up. b The OCT of the left eye showed multiple
PEDs. c The FFA of the left eye revealed mottled hyper- and hypofluorescence, and no definite focal leak was evident. d Early phase ICGA of the left
eye showed inferiorly enlarged choroidal vessels and granular fluorescence at the posterior pole. e Mid-phase ICGA revealed increased choroidal
permeability and few active pin point leaks (black arrowhead)
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patient after this particular intervention suggests that
the surgery was contributing to the resolution of the de-
tachment. We hypothesize that smaller eyes with com-
promised transscleral outflow may be at higher risk of
developing large exudative RDs in the presence of other
pathologies like chronic CSCR. These eyes may benefit
from partial thickness scleral resection surgery to im-
prove transscleral outflow. The limitation of our hypoth-
esis is that it is based upon a single case report and we
do not have long-term results after the surgery. Larger
case series with similar ocular parameters and longer
follow-up are required to further elaborate the role of
such procedures.
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